← All trials
NCT02585622
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2017
- Primary completion
- Apr 1, 2019
- Completion date
- Dec 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 48
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Mario Negri InstituteLead sponsor
- University of BirminghamOverall official - principal investigator
- Queen's University, BelfastOverall official - principal investigator
- National University of IrelandOverall official - principal investigator
- Leiden UniversityCollaborator
- NHS Blood and TransplantCollaborator
- Queen's University, BelfastCollaborator
- University of BirminghamCollaborator
- University of BresciaCollaborator
- Vita-Salute University of Milano. ItalyCollaborator
- National University of IrelandCollaborator
- University of BresciaStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.